Healthcare · PulsewellDemo
Will Pulsewell get FDA clearance by end of 2027?—Last trade
0 contracts tradedDec 31, 2027
Healthcare · Series A Demo
Pulsewell
Catching heart problems before the ER
19 followers
About Pulsewell
Pulsewell, founded by Dr. Samuel Okoye, makes a 14-day adhesive heart-rhythm monitor that flags atrial fibrillation and sends reports straight to the patient's clinician.
- Product
- Heart monitoring patch
- Founded
- Mar 2023
- Stage
- Series A
- Based in
- Cleveland, OH
- Verification
- Founder-reported
The product
A thin patch records a continuous ECG for 14 days. Pulsewell's software flags suspected atrial fibrillation and other arrhythmias, and a clinician portal lets doctors review the strips.
Active markets
1Videos
Progress and updates
- Clinical study results
A 400-patient study completed; the paper is under review (demo).
- FDA submission filed
Pulsewell filed a 510(k) premarket notification (demo).